The Oncology Institute Q1 EPS $(0.22) Misses $(0.12) Estimate, Sales $94.67M Miss $95.16M Estimate
The Oncology Institute Q1 EPS $(0.22) Misses $(0.12) Estimate, Sales $94.67M Miss $95.16M Estimate
腫瘤學研究所第一季度每股收益（0.22）未達到預期（0.12）美元，銷售額爲9,467萬美元，低於預期的9,516萬美元
The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.12) by 83.33 percent. This is a 33.33 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $94.67 million which missed the analyst consensus estimate of $95.16 million by 0.52 percent. This is a 24.25 percent increase over sales of $76.19 million the same period last year.
腫瘤學研究所（納斯達克股票代碼：TOI）公佈的季度虧損爲每股0.22美元，比分析師共識估計的0.12美元（0.12美元）低83.33％。與去年同期每股虧損0.33美元（0.33美元）相比，增長了33.33％。該公司公佈的季度銷售額爲9,467萬美元，比分析師普遍預期的9,516萬美元低0.52％。這比去年同期的7,619萬美元銷售額增長了24.25％。